Tardif, Jean-Claude Bouabdallaoui, Nadia L'Allier, Philippe L. and Gaudet, Daniel Shah, Binita Pillinger, Michael H. and Lopez-Sendon, Jose da Luz, Protasio Verret, Lucie Audet, Sylvia Dupuis, Jocelyn Denault, Andre Pelletier, Martin and Tessier, Philippe A. Samson, Sarah Fortin, Denis Tardif, Jean-Daniel Busseuil, David Goulet, Elisabeth Lacoste, Chantal Dubois, Anick Joshi, Avni Y. Waters, David D. and Hsue, Priscilla Lepor, Norman E. Lesage, Frederic Sainturet, Nicolas Roy-Clavel, Eve Bassevitch, Zohar Orfanos, Andreas and Stamatescu, Gabriela Gregoire, Jean C. Busque, Lambert and Lavallee, Christian Hetu, Pierre-Olivier Paquette, Jean-Sebastien Deftereos, Spyridon G. Levesque, Sylvie and Cossette, Marieve Nozza, Anna Chabot-Blanchet, Malorie Dube, Marie-Pierre Guertin, Marie-Claude Boivin, Guy COLCORONA Investigators, Colchicine for community-treated patients with COVID-19 (COLCORONA): a
phase 3, randomised, double-blinded, adaptive, placebo-controlled,
multicentre trial, The Lancet Respiratory Medicine, (9), 924-932, 2021, Elsevier Sci Ltd, Exeter, United Kingdom, 2213-2600